Ligand(LGND) - 2025 Q1 - Earnings Call Transcript

Ligand Pharmaceuticals (LGND) Q1 2025 Earnings Call May 08, 2025 08:30 AM ET Company Participants Melanie Herman - Executive Director - Investor Relations and FP&ATodd Davis - CEORichard Baxter - SVP, Investment OperationsTavo Espinoza - CFOLauren Hay - Vice President - Strategic Planning & Investment AnalyticsAnnabel Samimy - Managing Director Conference Call Participants Douglas Miehm - AnalystMatt Hewitt - Senior Research AnalystTrevor Allred - Biotech AnalystJohn Vandermosten - Senior Analyst Operator T ...